BNTC vs ERAS: stock comparison and AI forecast
Benitec Biopharma Inc. (BNTC) and Erasca, Inc. (ERAS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BNTC Benitec Biopharma Inc.
- Price
- $8.64 -28.8% · 6M
- Market Cap
- $293M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
ERAS Erasca, Inc.
- Price
- $13.27 +27.6% · 6M
- Market Cap
- $4.64B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ERAS is 15.9 times larger than BNTC by market capitalization ($4.64B against $293M).
- Over the last six months ERAS returned +27.6% and BNTC -28.8%.
- ERAS carries 0.20 times debt per unit of equity, against 0.03 times for BNTC.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BNTC | ERAS |
|---|---|---|
| Market Cap | $293M | $4.64B |
| P/B Ratio | 1.65x | 12.83x |
| EPS | $-0.98 | $-0.46 |
| Book Value/Share | $5.23 | $1.03 |
| FCF/Share | – | $-0.28 |
Profitability & Margins
| Metric | BNTC | ERAS |
|---|---|---|
| ROE | -25.7% | – |
| ROA | -24.9% | – |
| ROIC | -28.9% | -75.4% |
Financial Health
| Metric | BNTC | ERAS |
|---|---|---|
| Current Ratio | 34.00x | 8.29x |
| D/E Ratio | 0.03x | 0.20x |
| Financial Leverage | 1.03x | 1.20x |
| Working Capital | $176M | $245M |
Cash Flow
| Metric | BNTC | ERAS |
|---|---|---|
| Operating Cash Flow | -$17M | -$98M |
| Free Cash Flow | – | -$98M |
| Capital Spending | – | -$60K |
Income Statement
| Metric | BNTC | ERAS |
|---|---|---|
| Operating Income | -$51M | -$303M |
| Net Income | -$46M | – |
| R&D Expense | $23M | $109M |
Dividend & Shareholder Information
| Metric | BNTC | ERAS |
|---|---|---|
| Shares Outstanding | 34M | 350M |
BNTC vs ERAS: stock comparison and AI forecast
Which is bigger, BNTC or ERAS?
ERAS is 15.9 times larger than BNTC by market capitalization ($4.64B against $293M).
Which stock performed better over the last six months, BNTC or ERAS?
Over the last six months ERAS returned +27.6% and BNTC -28.8%.
Which one does Intratio's AI model rank higher, BNTC or ERAS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.